10243 Results for "

Targets

" in MedChemExpress (MCE) Product Catalog:
Products (10243)

10243 Results for "Targets" in MCE Product Catalog:

763
763 Publications Verification
Cat. No.: HY-13418
CAS No.: 1219168-18-9
Purity:  99.7%
Synonyms: Compound C dihydrochloride; BML-275 dihydrochloride
Research Areas:  

Cancer

Dorsomorphin (Compound C) dihydrochloride is a potent, selective and ATP-competitive AMPK inhibitor, with a Ki of 109 nM. Dorsomorphin dihydrochloride inhibits BMP pathway by targeting the type I receptors ALK2, ALK3, and ALK6. Dorsomorphin dihydrochloride can reverse autophagy activation and anti-inflammatory effect of Urolithin A (HY-100599).
202
202 Cited Publications
Cat. No.: HY-B0795
CAS No.: 326914-06-1
Target:  

mTOR Autophagy

Research Areas:  

Cancer

MHY1485 is a potent cell-permeable mTOR activator that targets the ATP domain of mTOR. MHY1485 inhibits autophagy by suppression of fusion between autophagosomes and lysosomes .
156
156 Cited Publications
Cat. No.: HY-100116A
CAS No.: 845959-50-4
Purity:  99.09%
Synonyms: MitoQ mesylate; MitoQ10 mesylate
Research Areas:  

Metabolic Disease Cancer

Mitoquinone mesylate is a TPP-based, mitochondrially targeted antioxidant in order to protect against oxidative damage .
113
113 Cited Publications
Cat. No.: HY-112906
CAS No.: 314054-00-7
Purity:  99.45%
Target:  

STING

Research Areas:  

Inflammation/Immunology

C-176 is a selective and blood-brain barrier permeable STING inhibitor. C-176 covalently targets transmembrane cysteine residue 91 and thereby blocking activation-induced palmitoylation of STING .
110
110 Cited Publications
Cat. No.: HY-138687
CAS No.: 2628280-40-8
Purity:  99.74%
Synonyms: PF-07321332
Target:  

SARS-CoV

Research Areas:  

Infection Inflammation/Immunology

Nirmatrelvir (PF-07321332) is a potent and orally active SARS-CoV 3C-like protease (3CL PRO) inhibitor. Nirmatrelvir (PF-07321332) targets to the SARS-CoV-2 virus and can be used for COVID-19 research .
101
101 Cited Publications
Cat. No.: HY-108331
CAS No.: 120241-79-4
Purity:  99.96%
3-TYP is an inhibitor of SIRT3 (IC50of 38 μM) and an inhibitor of Methionine Adenosyltransferase (MAT) 2 and Indoleamine 2,3-Dioxygenase (IDO). There may be many off-target sites for 3-TYP that need to be examined, such as NAD-dependent enzymes, including dehydrogenases .
96
96 Cited Publications
Cat. No.: HY-10255A
CAS No.: 557795-19-4
Purity:  99.04%
Synonyms: SU 11248
Research Areas:  

Cancer

Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively . Sunitinib, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation .
96
96 Cited Publications
Cat. No.: HY-10255
CAS No.: 341031-54-7
Purity:  99.86%
Synonyms: SU 11248 Malate
Sunitinib (SU 11248) Malat is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively . Sunitinib Malat, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation .
96
96 Cited Publications
Cat. No.: HY-10255C
CAS No.: 1818285-48-1
Synonyms: SU 11248 glucuronate
Research Areas:  

Cancer

Sunitinib (SU 11248) glucuronate is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively . Sunitinib glucuronate, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation .
95
95 Cited Publications
Cat. No.: HY-10981
CAS No.: 417716-92-8
Purity:  99.75%
Synonyms: E7080
Target:  

VEGFR FGFR PDGFR c-Kit RET

Research Areas:  

Cancer

Lenvatinib (E7080) is an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows potent antitumor activities .
95
95 Cited Publications
Cat. No.: HY-10981A
CAS No.: 857890-39-2
Purity:  99.86%
Synonyms: E7080 mesylate
Target:  

VEGFR FGFR PDGFR RET c-Kit

Research Areas:  

Cancer

Lenvatinib mesylate (E7080 mesylate), an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows potent antitumor activities .
93
93 Cited Publications
Cat. No.: HY-13308
CAS No.: 835621-07-3
Purity:  99.58%
Synonyms: BAY 73-4506 hydrochloride
Target:  

VEGFR Autophagy PDGFR Raf RET

Research Areas:  

Cancer

Regorafenib Hydrochloride (BAY 73-4506 hydrochloride) is a multi-target inhibitor for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1 with IC50s of 13/4.2/46, 22, 7, 1.5 and 2.5 nM, respectively .
67
67 Cited Publications
Cat. No.: HY-13901
CAS No.: 500579-04-4
Purity:  99.66%
Synonyms: NSC 136476
Target:  

Gli Autophagy

Research Areas:  

Cancer

GANT 61 is an inhibitor of Gli1 and Gli2 targeting the Hedgehog/GLI pathway.
66
66 Cited Publications
Cat. No.: HY-N0003
CAS No.: 35354-74-6
Synonyms: NSC 293100
Honokiol is a bioactive, biphenolic phytochemical that possesses potent antioxidative, anti-inflammatory, antiangiogenic, and anticancer activities by targeting a variety of signaling molecules. It inhibits the activation of Akt. Honokiol can readily cross the blood brain barrier .
62
62 Cited Publications
Cat. No.: HY-12238
CAS No.: 1127442-82-3
Purity:  99.60%
Synonyms: endo-IWR 1; IWR-1-endo
Target:  

Organoid Wnt

Research Areas:  

Inflammation/Immunology Cancer

IWR-1 (IWR-1-endo) is a tankyrase inhibitor targeting Wnt/β-catenin (IC50 = 180 nM). IWR-1 compromises critical steps of the canonical Wnt signaling, namely translocation of β-catenin to the nucleus and subsequent TCF/LEF activation and expression of Wnt/β-catenin downstream targets. IWR-1 promotes β-catenin phosphorylation by promoting stability of Axin-scaffolded destruction complexes. IWR-1 can be studied in research for anti-tumor purposes, and diseases such as osteosarcoma, colorectal cancer and psoriasis .
56
56 Cited Publications
Cat. No.: HY-14881A
CAS No.: 845533-86-0
Purity:  99.97%
Synonyms: R403323; TMC207 fumarate; R207910 fumarate
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Bedaquiline fumarate, a diarylquinoline antibiotic that targets ATP synthase, is effective for the treatment of Mycobacterium tuberculosis infections.
56
56 Cited Publications
Cat. No.: HY-12702
CAS No.: 403811-55-2
Purity:  99.49%
Target:  

c-Myc Autophagy

Research Areas:  

Cancer

10058-F4 is a c-Myc inhibitor that prevents c-Myc-Max dimerization and transactivation of c-Myc target gene expression.
56
56 Cited Publications
Cat. No.: HY-14881
CAS No.: 843663-66-1
Purity:  99.98%
Synonyms: TMC207; R207910
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Bedaquiline (TMC207) is a diarylquinoline agent and inhibits Mycobacterium tuberculosis (Mtb) F1FO-ATP synthase through targeting of both the c- and the ε-subunit . Bedaquiline has uncoupler activity. Bedaquiline is used for the multi-agent resistant tuberculosis .
55
55 Cited Publications
Cat. No.: HY-12047
CAS No.: 943319-70-8
Purity:  99.67%
Synonyms: AP24534
Ponatinib (AP24534) is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively .
55
55 Cited Publications
Cat. No.: HY-108766
CAS No.: 1114544-31-8
Purity:  99.76%
Synonyms: AP24534 hydrochloride
Research Areas:  

Infection Cancer

Ponatinib hydrochloride (AP24534 hydrochloride) is a hydrochloride of ponatinib. Ponatinib is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively .